Fate Therapeutics Inc (FATE): Shares Outstanding
115.36M
As of 2025-12-31
116.69M
As of 2026-06-30
+5.8%
3-year compound annual growth
+5.6%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 115.36M | +1.3% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 113.93M | +15.5% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 98.63M | +1.4% | 2025-03-05, Balance as of period end |
| 2022-12-31 | 97.29M | +1.6% | 2024-02-26, Balance as of period end |
| 2021-12-31 | 95.73M | +9.1% | 2023-02-28, Balance as of period end |
| 2020-12-31 | 87.72M | +15.8% | 2022-02-28, Balance as of period end |
| 2019-12-31 | 75.73M | +17.1% | 2021-02-24, Balance as of period end |
| 2018-12-31 | 64.69M | +22.9% | 2020-03-02, Balance as of period end |
| 2017-12-31 | 52.65M | +27.2% | 2019-03-05, Balance as of period end |
| 2016-12-31 | 41.39M | n/c | 2018-03-05, Balance as of period end |
| 2015-12-31 | 28.72M | +39.6% | 2017-03-16, Balance as of period end |
| 2014-12-31 | 20.57M | +0.7% | 2016-03-03, Balance as of period end |
| 2013-12-31 | 20.43M | n/m | 2015-03-12, Balance as of period end |
| 2012-12-31 | 1.33M | n/a | 2014-03-17, Balance as of period end |